1. Home
  2. AXS vs STVN Comparison

AXS vs STVN Comparison

Compare AXS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axis Capital Holdings Limited

AXS

Axis Capital Holdings Limited

HOLD

Current Price

$98.24

Market Cap

7.3B

Sector

Finance

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$20.90

Market Cap

5.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXS
STVN
Founded
2001
1949
Country
Bermuda
Italy
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Containers/Packaging
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
5.9B
IPO Year
2003
2021

Fundamental Metrics

Financial Performance
Metric
AXS
STVN
Price
$98.24
$20.90
Analyst Decision
Buy
Buy
Analyst Count
8
3
Target Price
$121.29
$25.67
AVG Volume (30 Days)
480.9K
367.1K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
1.80%
0.39%
EPS Growth
N/A
N/A
EPS
3.29
N/A
Revenue
$6,563,678,000.00
N/A
Revenue This Year
$2.53
$9.67
Revenue Next Year
$6.95
$9.99
P/E Ratio
$29.90
$27.15
Revenue Growth
10.17
N/A
52 Week Low
$88.07
$12.89
52 Week High
$119.99
$28.00

Technical Indicators

Market Signals
Indicator
AXS
STVN
Relative Strength Index (RSI) 41.26 48.70
Support Level $97.57 $20.17
Resistance Level $102.78 $22.00
Average True Range (ATR) 1.48 0.78
MACD 0.26 -0.24
Stochastic Oscillator 26.96 29.36

Price Performance

Historical Comparison
AXS
STVN

About AXS Axis Capital Holdings Limited

Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States (U.S.), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of Insurance and Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States, and also has its presence in Ireland, Lloyd's of London, and Bermuda.

About STVN Stevanato Group S.p.A.

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.

Share on Social Networks: